<DOC>
	<DOCNO>NCT02644408</DOCNO>
	<brief_summary>Megestrol semisynthetic progesterone derivative , promote anabolic effect . Can improve appetite , weight gain , improve bone marrow suppression , increase tolerance put , chemotherapy , improve quality life , widely use tumor radiation chemotherapy terminally ill patient . But vascular embolization , vaginal bleeding , arrhythmia serious complication , unified standard . The purpose study evaluate megestrol esophageal squamous carcinoma radical chemoradiation curative effect side effect , rational use process radiation chemotherapy megestrol provide guideline . A total 210 patient accrue China within 2 years.The primary endpoint overall survival secondary endpoint include gastrointestinal reaction body weight change , performance status , leucopenia deep venous thrombosis .</brief_summary>
	<brief_title>Effect Megestrol Acetate Quality Life Patients With Esophageal Carcinoma</brief_title>
	<detailed_description>The investigator plan recruit patient pathologically confirm esophageal squamous cell carcinoma perform chemoradiotherapy Oct 2014 . The patient divide two groups.Experimental group：esophageal cancer patient oral megestrol chemoradiation . Megestrol（Yining）：160mg/d，po,5 week total，oen week chemoradiotherapy one week chemoradiotherapy . chemoradiotherapy：chemotherapy radiotherapy： 50Gy total，2 Gy/d，5d/w.Control group : Esophageal cancer patient chemoradiation without oral megestrol.chemoradiotherapy：chemotherapy radiotherapy： 50Gy total，2 Gy/d，5d/w.To evaluate overall survival two group . Also observe patient 's gastrointestinal reaction body weight change , performance status , leucopenia deep venous thrombosis .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Age 4575years old Histologically proven squamous cell carcinoma esophagus tumor T24N02M0 The patient receive surgery chemoradiotherapy . Hb≥80g/L , absolute neutrophil count ≥1.5×109/L , Plt≥90×109/L , ALT、AST≤2.5*N , Cr≤1.5*N. performance status score 02 Pregnant , lactate woman Oxaliplatin fluorouracil Allergy metabolic disorder Radiotherapy contraindication History organ transplantation Brain metastasis The peripheral nervous system disorder Severe infection Oral capecitabine difficulty , dysphagia , The activity digestive ulcer , Gastrointestinal bleeding Severe chronic disease , , hepatopathy , nephropathy , respiratory disease , high blood pressure , diabetes . Other malignant tumor recent 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Esophageal Squamous Cancer</keyword>
	<keyword>Megestrol</keyword>
</DOC>